Abstract
Randomized controlled trials investigating the efficacy and safety of fecal microbiota transplantation (FMT) for recurrent Clostridioides difficile infection (CDI) are reviewed, and practical issues for pharmacists to consider are discussed. Eight randomized controlled trials evaluating the use of FMT for recurrent CDI were analyzed. The trials varied in the type of sample (fresh, frozen, lyophilized), route of administration (nasogastric tube, colonoscopy, enema, oral), and comparator agent (different type of FMT, vancomycin). Efficacy rates ranged from 43.8% to 96.2% with FMT, and safety data were relatively similar. With these favorable data, pharmacists are likely to be involved at multiple steps in the delivery of FMT to patients with recurrent CDI, including the procurement, documentation, and administration of various products and patient education. FMT is an option for recurrent CDI that is supported by findings of randomized controlled trials, although a preferred method for the delivery remains to be defined. Pharmacists can play an important role in the successful management of patients with recurrent CDI who may benefit from FMT.
References
Aug 19, 2010·Journal of Clinical Gastroenterology·Martin J GrehanAntony Wettstein
Mar 9, 2012·International Journal of Antimicrobial Agents·Konstantinos Z VardakasMatthew E Falagas
Jan 18, 2013·The New England Journal of Medicine·Els van NoodJosbert J Keller
Mar 22, 2014·Der Internist·T SeufferleinS Nitschmann
Feb 14, 2015·Infectious Disease Clinics of North America·Jennie H KwonErik R Dubberke
Feb 26, 2015·The New England Journal of Medicine·Fernanda C LessaL Clifford McDonald
Mar 3, 2015·Alimentary Pharmacology & Therapeutics·G CammarotaA Gasbarrini
May 6, 2015·Annals of Internal Medicine·Dimitri DrekonjaTimothy J Wilt
Jan 13, 2016·JAMA : the Journal of the American Medical Association·Christine H LeePeter T Kim
May 26, 2016·MMW Fortschritte der Medizin·Bernhard RamsauerJan-Michel Otte
Nov 1, 2016·Annals of Internal Medicine·Colleen R KellyLawrence J Brandt
Dec 25, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Susy S HotaSusan M Poutanen
Feb 22, 2017·Alimentary Pharmacology & Therapeutics·Z D JiangH L DuPont
Nov 29, 2017·JAMA : the Journal of the American Medical Association·Dina KaoThomas Louie
Dec 20, 2017·Open Forum Infectious Diseases·Laura J CravenMichael S Silverman
Dec 21, 2017·PloS One·Adrián Camacho-OrtizElvira Garza-González
Mar 22, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L Clifford McDonaldMark H Wilcox
Jun 5, 2018·The New England Journal of Medicine·Frederik E JuulHans-Olov Adami
Citations
Oct 30, 2020·Microorganisms·Nicola PrincipiSusanna Esposito
Feb 23, 2021·Frontiers in Microbiology·Renli QiZuohua Liu
Jan 27, 2021·Antimicrobial Agents and Chemotherapy·Daisuke OkaMakoto Matsumoto
Aug 18, 2020·Anaerobe·Asma Gasmi BenahmedGeir Bjørklund